Anand Deshmukh

NATCO Pharma

Natco Pharma Limited was incorporated in Hyderabad in the year 1981. Starting off as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc. NATCO is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs)which makes finished dosage formulations and active pharmaceutical ingredients. The company's focus is primarily on niche therapeutic areas and complex products. It is the market leader in branded oncology medicines in India, and among the country's top three producers of hepatitis C drugs. It is well recognized for its innovation in pharmaceutical research and development (R&D). NATCO also exports its finished products through its subsidiaries in over 40 countries and collectively over 30 products across these geographies. ○ NATCOFARMA DO BRASIL (since 2011), ○ NATCO PHARMA CANADA INC. (since 2012), ○ NATCO PHARMA Asia Pte. Ltd. (since 2012) ○ NATCO Pharma Australia PTY Ltd. (since 2014).